Obefazimod
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Obefazimod is an investigational new drug that is being evaluated for the treatment of ulcerative colitis. It is miR-124 micro RNA upregulator. Obefazimod was developed by the French biotech company Abivax SA, whose shares rose by more than 500% when the phase 3 data showed promising results.
Obefazimod is an investigational new drug that is being evaluated for the treatment of ulcerative colitis. It is miR-124 micro RNA upregulator. Obefazimod was developed by the French biotech company Abivax SA, whose shares rose by more than 500% when the phase 3 data showed promising results.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1330448738 under CC BY-SA 4.0; modifications have been made.